With respect to tolerability concerns with the recommended paliperidone palmitate initiation dosing, this study did not reveal unexpected adverse events or high rates of specific adverse events in ...
Paliperidone (as palmitate) 39mg, 78mg, 117mg, 156mg, 234mg; ext-rel susp for IM inj. Establish tolerability with oral paliperidone or oral risperidone prior to initiating. Give by deep deltoid IM ...
That includes Johnson & Johnson's blockbuster Invega (paliperidone) range, which includes once-monthly (Invega Sustenna), three-monthly (Invega Trinza) and six-monthly version (Invega Hafyera), as ...
Min-Wei Huang; Tsung-Tsair Yang; Po-Ren Ten; Po-Wen Su; Bo-Jian Wu; Chin-Hong Chan; Tsuo-Hung Lan; I-Chao Liu; Wei-Cheh Chiu; Chun-Ying Li; Kuo-Sheng Cheng; Yu-Chi Yeh ...
INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat schizophrenia in adults (18 years of age and older). For more information, see Section 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback